# Synchrony Financial (SYF) stock news and updates

As of November 18, 2026. Source: https://www.clearthesis.ai/updates/SYF

## Our view on the Synchrony Financial investment thesis

Full investment thesis: https://www.clearthesis.ai/thesis/SYF

## Latest updates on Synchrony Financial

### Federal Reserve governor warns interest rates may need to rise further

*November 18, 2026 · macro · significance: notable · signal: watch*

Federal Reserve Governor Christopher Waller suggested on Wednesday that the central bank might need to raise interest rates by another full percentage point to control inflation. He noted that a more aggressive approach might be required if price increases continue to change how the public thinks about spending and costs. For a lender like Synchrony, higher rates are a double-edged sword. While they can increase the interest the bank earns on credit card balances, they also raise the cost of the money the bank borrows to fund those loans. Most importantly, if rates stay high for longer, it puts more pressure on the household budgets of its borrowers, which can lead to more people falling behind on their payments.

Sources: [Market Watch](https://www.marketwatch.com/story/how-high-must-interest-rates-go-to-cool-inflation-possibly-100-basis-points-or-more-feds-waller-says-e7b41cf6)

### Holiday survey shows shoppers sticking with trusted retailers and rewards

*November 9, 2026 · news · significance: minor · signal: positive*

Synchrony's latest consumer research found that 83 percent of shoppers plan to do most of their holiday buying at retailers they already know and trust. The study also showed a sharp rise in the number of people planning to use earned rewards, which is up 13 percentage points from last year. This is a helpful trend for Synchrony because its entire business is built on store-branded credit cards. When shoppers stay loyal to specific retailers rather than hunting for deals everywhere, they are more likely to use their store cards and engage with the loyalty programs Synchrony manages for its partners.

Sources: [PRNewsWire](https://www.prnewswire.com/news-releases/shoppers-are-making-their-lists-and-checking-their-favorite-retailers-first-302932438.html)

### New pet insurance integration aims to simplify veterinary payments

*October 28, 2026 · product · significance: minor · signal: positive*

Synchrony's CareCredit arm is integrating its financing tools with the Clarus Technology Portal, giving veterinary offices a single view of a customer's insurance coverage and credit options. The goal is to help pet owners understand their out-of-pocket costs immediately so they can approve treatments faster. This move strengthens Synchrony's position in the healthcare market, which is a key part of its growth plan. By embedding its credit products directly into the software that veterinarians use every day, the company makes its financing the easiest and most obvious choice for customers facing large, unexpected bills.

Sources: [PRNewsWire](https://www.prnewswire.com/news-releases/carecredit-and-clarus-make-checkout-simpler-for-veterinary-practices-with-real-time-eligibility-insights-for-insurance-and-financing-options-302921244.html)

### Evercore ISI lowers rating to In Line

*October 21, 2026 · analyst · significance: major · signal: neutral*

Evercore ISI downgraded Synchrony to In Line, a rating that suggests they expect the stock to perform about as well as the broader market rather than beating it. This shift came shortly after the company reported its third-quarter earnings. While the bank's recent profits were higher than analysts expected, the downgrade reflects a more cautious view of the path ahead. It suggests that while the business remains stable, the firm sees fewer immediate reasons for the stock to rise significantly compared to other options in the financial sector.

Sources: Evercore ISI Group

### CareCredit launches installment loan option for health and wellness

*October 21, 2026 · product · significance: notable · signal: positive*

Synchrony is expanding its CareCredit platform with a new installment loan product called CareCredit Pay Later. This allows patients to choose between a traditional credit card or a fixed-payment loan when paying for medical or wellness services, with both options presented digitally at the point of sale. Adding installment loans helps Synchrony compete with newer fintech firms that offer similar "buy now, pay later" services. By offering more ways to pay, the company can capture a wider range of customers who might prefer the predictability of a fixed loan over a revolving credit card balance, keeping them within the Synchrony ecosystem.

Sources: [PRNewsWire](https://www.prnewswire.com/news-releases/carecredit-introduces-carecredit-pay-later-offering-consumers-another-way-to-plan-and-pay-for-health-and-wellness-care-302914817.html)

## Synchrony Financial earnings

In Q3 2026, reported on October 20, 2026, Synchrony Financial posted earnings of $2.68 per share against $2.42 expected, and revenue of $3.8 billion against $3.8 billion expected.

The next earnings report is expected on January 26, 2027. Analysts expect $2.00 per share. Revenue is expected around $3.9 billion.

What to watch: We are watching the efficiency ratio to see if the company can lower its operating costs toward our target as it fixes the one-time losses that weighed on recent results.

## Recent analyst activity on SYF

- November 2, 2026: UBS Kept rating at Neutral.
- October 21, 2026: Barclays Kept rating at Overweight, raised target from $93. Price target: $94.00.
- October 21, 2026: JP Morgan Kept rating at Neutral.
- October 21, 2026: Evercore ISI Group Downgraded to In Line.
- October 21, 2026: J.P. Morgan Raised target from $74. Price target: $77.00.
- October 21, 2026: Evercore ISI Set target. Price target: $78.00.

## What's ahead for Synchrony Financial

- January 26, 2027: Earnings report — The company shows how it did over the last three months. The most important update for the stock.

---

Published by Clearthesis (https://www.clearthesis.ai). Informational only, not investment advice.
Full page: https://www.clearthesis.ai/updates/SYF
